Cargando…
Evaluation of an automated system for the quantitation of human Herpesvirus-6 DNA from clinical specimens
BACKGROUND: Quantitation of human herpesvirus-6 (HHV-6) DNA in clinical specimens is important for the diagnosis and management of HHV-6-associated infection and reactivation in immunocompromised patients, particularly transplant recipients. METHODS: The analytical performance of the Altona RealStar...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462668/ https://www.ncbi.nlm.nih.gov/pubmed/37649537 http://dx.doi.org/10.1016/j.plabm.2023.e00329 |
_version_ | 1785098082075017216 |
---|---|
author | Mah, Jordan Huang, ChunHong Sahoo, Malaya K. Pinsky, Benjamin A. |
author_facet | Mah, Jordan Huang, ChunHong Sahoo, Malaya K. Pinsky, Benjamin A. |
author_sort | Mah, Jordan |
collection | PubMed |
description | BACKGROUND: Quantitation of human herpesvirus-6 (HHV-6) DNA in clinical specimens is important for the diagnosis and management of HHV-6-associated infection and reactivation in immunocompromised patients, particularly transplant recipients. METHODS: The analytical performance of the Altona RealStar ASR HHV-6 qPCR on the semi-automated AltoStar AM16 system was assessed using HHV-6 reference material in plasma and cerebral spinal fluid (CSF). Qualitative and quantitative agreement was determined using 123 clinical EDTA plasma specimens tested using a laboratory-developed HHV-6 qPCR. RESULTS: The 95% Lower Limit of Detection was 20 IU/mL [95% confidence interval (CI): 10 to 29] in plasma and 78 IU/mL (95% CI: 55 to 146) in CSF. The assay was linear from 7.0 to 2.0 log(10) IU/mL in both matrices. Overall agreement of the RealStar ASR HHV-6 qPCR on the AltoStar AM16 with a laboratory-developed test was 95.9% (95% CI: 90.8 to 98.7). Passing-Bablok analysis of specimens quantifiable by both methods and at levels >1000 copies/mL revealed a regression line of Y = 1.00*X–0.20, with neither systematic (95% CI Y-intercept: −0.66 to 0.26) nor proportional (95% CI slope: 0.89 to 1.10) bias compared to the reference. CONCLUSIONS: The RealStar ASR HHV-6 qPCR on the AltoStar AM16 provides accurate quantitation for clinical monitoring of HHV-6 in immunocompromised hosts. |
format | Online Article Text |
id | pubmed-10462668 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-104626682023-08-30 Evaluation of an automated system for the quantitation of human Herpesvirus-6 DNA from clinical specimens Mah, Jordan Huang, ChunHong Sahoo, Malaya K. Pinsky, Benjamin A. Pract Lab Med Original Research Article BACKGROUND: Quantitation of human herpesvirus-6 (HHV-6) DNA in clinical specimens is important for the diagnosis and management of HHV-6-associated infection and reactivation in immunocompromised patients, particularly transplant recipients. METHODS: The analytical performance of the Altona RealStar ASR HHV-6 qPCR on the semi-automated AltoStar AM16 system was assessed using HHV-6 reference material in plasma and cerebral spinal fluid (CSF). Qualitative and quantitative agreement was determined using 123 clinical EDTA plasma specimens tested using a laboratory-developed HHV-6 qPCR. RESULTS: The 95% Lower Limit of Detection was 20 IU/mL [95% confidence interval (CI): 10 to 29] in plasma and 78 IU/mL (95% CI: 55 to 146) in CSF. The assay was linear from 7.0 to 2.0 log(10) IU/mL in both matrices. Overall agreement of the RealStar ASR HHV-6 qPCR on the AltoStar AM16 with a laboratory-developed test was 95.9% (95% CI: 90.8 to 98.7). Passing-Bablok analysis of specimens quantifiable by both methods and at levels >1000 copies/mL revealed a regression line of Y = 1.00*X–0.20, with neither systematic (95% CI Y-intercept: −0.66 to 0.26) nor proportional (95% CI slope: 0.89 to 1.10) bias compared to the reference. CONCLUSIONS: The RealStar ASR HHV-6 qPCR on the AltoStar AM16 provides accurate quantitation for clinical monitoring of HHV-6 in immunocompromised hosts. Elsevier 2023-08-05 /pmc/articles/PMC10462668/ /pubmed/37649537 http://dx.doi.org/10.1016/j.plabm.2023.e00329 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original Research Article Mah, Jordan Huang, ChunHong Sahoo, Malaya K. Pinsky, Benjamin A. Evaluation of an automated system for the quantitation of human Herpesvirus-6 DNA from clinical specimens |
title | Evaluation of an automated system for the quantitation of human Herpesvirus-6 DNA from clinical specimens |
title_full | Evaluation of an automated system for the quantitation of human Herpesvirus-6 DNA from clinical specimens |
title_fullStr | Evaluation of an automated system for the quantitation of human Herpesvirus-6 DNA from clinical specimens |
title_full_unstemmed | Evaluation of an automated system for the quantitation of human Herpesvirus-6 DNA from clinical specimens |
title_short | Evaluation of an automated system for the quantitation of human Herpesvirus-6 DNA from clinical specimens |
title_sort | evaluation of an automated system for the quantitation of human herpesvirus-6 dna from clinical specimens |
topic | Original Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462668/ https://www.ncbi.nlm.nih.gov/pubmed/37649537 http://dx.doi.org/10.1016/j.plabm.2023.e00329 |
work_keys_str_mv | AT mahjordan evaluationofanautomatedsystemforthequantitationofhumanherpesvirus6dnafromclinicalspecimens AT huangchunhong evaluationofanautomatedsystemforthequantitationofhumanherpesvirus6dnafromclinicalspecimens AT sahoomalayak evaluationofanautomatedsystemforthequantitationofhumanherpesvirus6dnafromclinicalspecimens AT pinskybenjamina evaluationofanautomatedsystemforthequantitationofhumanherpesvirus6dnafromclinicalspecimens |